Found 5 matching trials
Neoadjuvant Adebrelimab With Dalpiciclib for Resectable Esophageal Squamous Cell Carcinomas PHASE1 The purpose of this study is to explore the safety and feasibility of anti-...
Show More Location
West China Hospital, Sichuan University
Learn More & Join Trial
Neoadjuvant Adebrelimab Plus Dalpiciclib in Head and Neck Squamous Cell Carcinoma PHASE2 This study is a single arm phase II trial including 30 patients with III-IV...
Show More Location
Multiple Locations
Learn More & Join Trial
Adebrelimab Combined With Dalpiciclib and Standard Endocrine Therapy for HR+/HER2 - Advanced Breast Cancer PHASE2 This is a prospective, single-arm, multicenter Phase II study of patients w...
Show More Location
Tongji Hospital Affiliated of Tongji Medical College Huazhong University of Science and Technology
Learn More & Join Trial
Adebrelimab Combined With Dalpiciclib and Standard Endocrine Therapy for HR + / HER2- Breast Cancer PHASE2 This study intends to explore the efficacy and safety of PD-L1 inhibitor Ad...
Show More Status
Active Not Recruiting
Location
Harbin Medical Cancer Hospital
Learn More & Join Trial
Adebrelimab Combined With Dalpiciclib Isethionate Plus Chemotherapy for Neoadjuvant Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma PHASE2 This single-center, open-label Phase II trial aims to evaluate the efficacy...
Show More Location
Multiple Locations
Learn More & Join Trial